Hizentra

subcutaneous immunoglobulin (IgG) · CSL Behring

Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for Hizentra, covering 2011-02-11 to 2025-11-24. Get the full timeline:

Most recent: EMA Authorised: Hizentra (human normal immunoglobulin (SCIg)) — CSL Behring GmbH